Athira Pharma, Inc. (ATHA) Tops Q2 EPS by 4c
Athira Pharma, Inc. (NASDAQ: ATHA) reported Q2 EPS of ($0.70), $0.04 better than the analyst estimate of ($0.74).
For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.
Athira Pharma, Inc. (NASDAQ: ATHA) reported Q2 EPS of ($0.70), $0.04 better than the analyst estimate of ($0.74).
For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.